Exciting drug developments in chronic lymphocytic leukemia (CLL)
Why do many MM patients relapse after being treated with targeted therapy?
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
Harnessing T-cells in acute leukemia and an anti-CD33/CD3 BiTE antibody
Pembrolizumab consolidation therapy in multiple myeloma